Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 04 tags : Car-t save search
Precision BioSciences Announces Two Oral Presentations Highlighting Updated Interim Data from Lead PBCAR0191 CAR T Immunotherapy
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
DTIL | $10.075 -1.52% 16K
|
Health Technology
|
| O: 1.0%
H: 0.0%
C: 0.0%
presentation immunotherapy therapy car-t bioscience
New data at ASH spotlight Novartis recently approved Scemblix®, next-generation CAR-T platform and expanding hematology portfolio
Published: 2021-11-04 (Crawled : 15:15) - globenewswire.com
NVSEF | News | $96.0 52K
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: -0.89%
NVS | News | $97.755 0.49% 1.1M
|
Health Technology
|
| O: -0.06%
H: 0.28%
C: 0.18%
INCY | $51.4 -0.48% 380K
|
Health Technology
|
| O: 2.41%
H: 0.0%
C: 0.0%
ema car-t platform
Mustang Bio Announces MB-106 CD20-Targeted CAR T Data Selected for Presentation at 63rd American Society of Hematology (ASH) Annual Meeting
Published: 2021-11-04 (Crawled : 15:15) - globenewswire.com
MBIO | $0.35 -2.7% 61K
|
Health Technology
|
| O: -0.4%
H: 0.02%
C: -3.64%
FBIO | $1.79 -1.11% 81K
|
Health Technology
|
| O: -0.82%
H: 0.28%
C: -3.04%
presentation ema car-t
Legend Biotech Showcases Updated and New Data from Comprehensive BCMA CAR-T, Cilta-Cel, Program and First Preclinical Results for Tri-specific CAR-T at 2021 ASH
Published: 2021-11-04 (Crawled : 14:00) - biospace.com/
LEGN | News | $46.09 -2.87% 350K
|
Health Technology
|
| O: -1.14%
H: 1.45%
C: -4.71%
car-t results biotech iot preclinical cel pre-clinical
Gracell Biotechnologies to Present Preclinical Results of TruUCAR-enabled CD19/CD7 Dual-Directed Allogeneic CAR-T Cell Therapy (GC502) for B-Cell Malignancies at the 63rd ASH Annual Meeting
Published: 2021-11-04 (Crawled : 13:00) - prnewswire.com
GRCL | $10.25 -0.29% 6.4M
|
Manufacturing
| Email alert
Add to watchlist
therapy car-t results biotech iot preclinical t-cell pre-clinical
Celyad Oncology to Present Updates from Allogeneic and Autologous CAR T Programs at 63rd ASH Annual Meeting and Exposition
Published: 2021-11-04 (Crawled : 13:00) - celyad.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: -2.78%
H: 2.38%
C: -0.95%
car-t
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
RCAT | $1.53 27.5% 2.9M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.